6Bruce Band Cerami A. The Biology of cachectim TNF-α primarg mediator of th e host response. Ann Rev Immunol 1989;7:625
7Nohynelk H, Teppo AM, Laine E, et al. Serum tumor necrsis factor-α concent rations in children hosipitalized for acute lower respiratory infecion. J Infect Dis 1991;163:1029
8Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infection in children with wheezing [J]. Eur Resp J, 2002, 16(9):1142-1146.
9Principi N, Esposito S, Blasi F, et al. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections[J]. Clin Infect Dis, 2001, 32(7):1281-1289.
10Dorigo-Zelsma, Zaat JW, Zaat SAT, et al Comparison of PCR, Culture and Serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children[J]. J Clin Microbol, 1999, 37(1):14-21.
2Morozumi M, Chiba N, Okada T, et al.Antibintie susceptibility in relation to genotype of Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae responsible community-acqnired pneumonia in children[J].Journal of Infection and Chemotherapy, 2013, 19(3): 430- 440.
3Miyashita N, Akaike H, Teranishi H, et al.Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Adolescents and Adults: Clinical Findings, Drug Susceptibility, and Therapeutic Efficacy[J].Antimicrobial agents and chemotherapy, 2013, 57(10): 5181-5185.
4Kawai Y, Miyashita N, Kubo M, et al.Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients[J].Antimicrobial agents and chemotherapy, 2013, 57(5): 2252-2258.
5Farr B M, Kaiser D L, Harrison B D, et al.Predietion of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee[J]. Thorax, 1989, 44(12): 1031-1035.
